NOT MEDICAL ADVICE. No information on this site should be considered medical advice. Research peptides are not intended for human consumption — in-vitro lab use only. Consult a physician prior to introducing anything into the human body.
Peptide HubResearch Peptide Wiki
Support Us Join

Home/Immune & Antimicrobial/Thymalin

Thymalin

A calf-thymus peptide preparation developed in Russia as an immune bioregulator, studied for immune aging and T-cell function.

Overview

Thymalin is a peptide preparation derived from calf thymus, developed in Russia as an immune-modulating bioregulator and registered there for clinical use in immune deficiency and age-related immune decline. It belongs to the family of short thymic peptide preparations and is typically described as a polypeptide complex rather than a single defined sequence. Internationally it is sold as a research peptide.

Mechanism

Thymic peptide preparations are proposed to restore T-cell-mediated immunity by promoting lymphocyte differentiation and maturation and by modulating cytokine balance. Thymalin is reported to normalize immune parameters in aged or immunosuppressed models. Because it is a tissue-derived complex, its exact molecular constituents and targets are not fully defined.

Dosing

Russian clinical protocols have typically used intramuscular injection over short courses. International research use follows supplier protocols, and no standardized research dose exists.

  • Intramuscular administration in documented Russian clinical use
  • Short treatment courses are typical in clinical protocols
  • Vendor-specific research protocols vary widely

Expected Effects

  • Improved T-cell function markers in Russian studies of immune aging
  • Reported normalization of immune parameters in immunocompromised animal models
  • Proposed support of immune recovery after stress or infection

Side Effects & Tolerability

Russian clinical literature describes thymalin as well tolerated, and documented adverse effects are limited. Independent, large-scale safety and efficacy data are lacking outside the Russian evidence base.

Storage

Lyophilized peptide should be stored cold and desiccated, protected from light and moisture. Reconstituted solutions are typically aliquoted and refrigerated or frozen, avoiding repeated freeze-thaw cycles.

Related peptides

Beta-Defensin Analogs (Expanded)Catalog grouping of products sold as beta-defensin-related analogs; no sequences or activities are documented.Cathelicidin Peptide AnalogsGeneric category of marketed cathelicidin-related peptides; the human cathelicidin LL-37 is real, these products are not documented.Defensin AnalogsGeneric category of marketed defensin-related peptides; defensins are real antimicrobial peptides, but these products are not documented.G-CSF Peptide AnalogsCatalog heading for small peptide products claimed to mimic G-CSF; clinically used G-CSF agents are recombinant cytokine proteins, not small peptides.Histamine-Regulating AnalogsVague catalog heading for peptides claimed to modulate histamine pathways; no defined compound or published research identity.Immune Resilience Capstone AnalogsPromotional catalog category for immune-related peptide groupings; no fixed composition or published research identity.